Skip to content
Disclosery

KINNEVIK AB (PUBL)

Follow

13F filer, CIK 1766574, STOCKHOLM, Sweden

KINNEVIK AB (PUBL) reported $67,976,906 across 1 holding for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001415889-25-021634

Period
2025-06-30
Reported value
$68M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001415889-25-021634, largest first. % of portfolio is the value over $67,976,906, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: 10,405,668 shares; 2024Q1: 10,405,668 shares; 2024Q2: 11,905,668 shares; 2024Q3: 11,905,668 shares; 2024Q4: 11,905,668 shares; 2025Q1: 13,434,171 shares; 2025Q2: 13,434,171 shares 13,434,171$68M100%0Timeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001415889-25-021634 base2025-08-13acceptance time not in the bulk data set